Human gene mutation: Mechanisms and consequences

Vogel and Motulsky's Human Genetics: Problems and Approaches (Fourth Edition)

Volumn , Issue , 2010, Pages 319-363

  Antonarakis, Stylianos E ^a   Cooper, David N ^b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884684738     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-37654-5_12     Document Type: Chapter

References (367)

1. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, Davis NR, Ercan-Sencicek AG, Guez DH, Spertus JA, Leckman JF, LSt D, Kurlan R, Singer HS, Gilbert DL, Farhi A, Louvi A, Lifton RP, Sestan N, State MW (2005) Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310:317-320.
2. Abeysinghe SS, Chuzhanova N, Krawczak M, Ball EV, Cooper DN (2003) Translocation and gross deletion breakpoints in human inherited disease and cancer. I nucleotide composition and recombination-associated motifs. Hum Mutat 22:229-244.
3. Abeysinghe SS, Stenson PD, Krawczak M, Cooper DN (2004) Gross rearrangement breakpoint database (GRaBD). Hum Mutat 23:219-221.
4. Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, Kariuki S, Nahlen BL, Lal AA, Udhayakumar V (2002) Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 359:1311-1312.
5. Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, Hodges MD, Bhangal G, Patel SG, Sheehan-Rooney K, Duda M, Cook PR, Evans DJ, Domin J, Flint J, Boyle JJ, Pusey CD, Cook HT (2006) Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439:851-855.
6. Alber T (1989) Mutational effects on protein stability. Annu Rev Biochem 58:765-798.
7. Aldred MA, Trembath RC (2000) Activating and inactivating mutations in the human GNAS1 gene. Hum Mutat 16: 183-189.
8. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P (2005) A haplotype map of the human genome. Nature 437:1299-1320.
9. Aly AM, Higuchi M, Kasper CK, Kazazian HH Jr, Antonarakis SE, Hoyer LW (1992) Hemophilia A due to mutations that create new N-glycosylation sites. Proc Natl Acad Sci USA 89:4933-4937.
10. Anagnou NP, O'Brien SJ, Shimada T, Nash WG, Chen MJ, Nienhuis AW (1984) Chromosomal organization of the amplifi cation, and a novel form of polymorphism. Proc Natl Acad Sci USA 81:5170-5174.
11. Antonarakis SE, McKusick VA (2000) OMIM passes the 1, 000-disease-gene mark. Nat Genet 25:11.
12. Antonarakis SE, Irkin SH, Cheng TC, Scott AF, Sexton JP, Trusko SP, Charache S, Kazazian HH Jr (1984) beta-Thalassemia in American Blacks: Novel mutations in the "TATA" box and an acceptor splice site. Proc Natl Acad Sci USA 81:1154-1158.
13. Antonarakis SE, Kazazian HH Jr, Orkin SH (1985) DNA polymorphism and molecular pathology of the human globin gene clusters. Hum Genet 69:1-14.
14. Antonarakis SE, Kazazian HH, Tuddenham EG (1995) Molecular etiology of factor VIII deficiency in hemophilia A. Hum Mutat 5:1-22.
15. Antonarakis SE, Krawczak M, Cooper DN (2001) The nature and mechanisms of human gene mutation. In: Scriver CR, Beaudet AL, Valle D et al (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 343-377.
16. Arai M, Inaba H, Higuchi M, Antonarakis SE, Kazazian HH Jr, Fujimaki M, Hoyer LW (1989) Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372-histidine). Proc Natl Acad Sci USA 86:4277-4281.
17. Armanios M, Chen JL, Chang YP, Brodsky RA, Hawkins A, Griffin CA, Eshleman JR, Cohen AR, Chakravarti A, Hamosh A, Greider CW (2005) Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci USA 102:15960-15964.
18. Athanassiadou A, Papachatzopoulou A, Zoumbos N, Maniatis GM, Gibbs R (1994) A novel beta-thalassaemia mutation in the 5' untranslated region of the beta-globin gene. Br J Haematol 88:307-310.
19. Audrezet MP, Chen JM, Raguenes O, Chuzhanova N, Giteau K, Le Marechal C, Quere I, Cooper DN, Ferec C (2004) Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms. Hum Mutat 23:343-357.
20. Bacolla A, Jaworski A, Larson JE, Jakupciak JP, Chuzhanova N, Abeysinghe SS, O'Connell CD, Cooper DN, Wells RD (2004) Breakpoints of gross deletions coincide with non-B DNA conformations. Proc Natl Acad Sci USA 101:14162-14167.
21. Baglioni C (1962) The fusion of two peptide chains in hemoglobin Lepore and its interpretation as a genetic deletion. Proc Natl Acad Sci USA 48:1880-1886.
22. Bailey JA, Gu Z, Clark RA, Reinert K, Samonte RV, Schwartz S, Adams MD, Myers EW, Li PW, Eichler EE (2002) Recent segmental duplications in the human genome. Science 297:1003-1007.
23. Ball EV, Stenson PD, Abeysinghe SS, Krawczak M, Cooper DN, Chuzhanova NA (2005) Microdeletions and microinsertions causing human genetic disease: common mechanisms of mutagenesis and the role of local DNA sequence complexity. Hum Mutat 26:205-213.
24. Ballabio A, Carrozzo R, Parenti G, Gil A, Zollo M, Persico MG, Gillard E, Affara N, Yates J, Ferguson-Smith MA et al (1989) Molecular heterogeneity of steroid sulfatase deficiency: A multicenter study on 57 unrelated patients, at DNA and protein levels. Genomics 4:36-40.
25. Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D, Grosveld G, Ferguson- Smith MA, Davies T, Stone M et al (1983) Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 306:277-280.
26. Becker J, Schwaab R, Moller-Taube A, Schwaab U, Schmidt W, Brackmann HH, Grimm T, Olek K, Oldenburg J (1996) Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies. Am J Hum Genet 58:657-670.
27. Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS, Haussler D (2004) Ultraconserved elements in the human genome. Science 304:1321-1325.
28. Benz EJ, Forget BG, Hillman DG, Cohen-Solal M, Pritchard J, Cavallesco C, Prensky W, Housman D (1978) Variability in the amount of beta-globin mRNA in beta0 thalassemia. Cell 14:299-312.
29. Berg LP, Scopes DA, Alhaq A, Kakkar VV, Cooper DN (1994) Disruption of a binding site for hepatocyte nuclear factor 1 in the protein C gene promoter is associated with hereditary thrombophilia. Hum Mol Genet 3:2147-2152.
30. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67.
31. Beysen D, Raes J, Leroy BP, Lucassen A, Yates JR, Clayton- Smith J, Ilyina H, Brooks SS, Christin-Maitre S, Fellous M, Fryns JP, Kim JR, Lapunzina P, Lemyre E, Meire F, Messiaen LM, Oley C, Splitt M, Thomson J, Peer YV, Veitia RA, De Paepe A, De Baere E (2005) Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. Am J Hum Genet 77:205-218.
32. Blencowe BJ (2000) Exonic splicing enhancers: Mechanism of action, diversity and role in human genetic diseases. Trends Biochem Sci 25:106-110.
33. Boffelli D, Nobrega MA, Rubin EM (2004) Comparative genomics at the vertebrate extremes. Nat Rev Genet 5:456-465.
34. Bondeson ML, Dahl N, Malmgren H, Kleijer WJ, Tonnesen T, Carlberg BM, Pettersson U (1995) Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome. Hum Mol Genet 4:615-621.
35. Borrell-Pages M, Zala D, Humbert S, Saudou F (2006) Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci 63: 2642-2660.
36. Botstein D, Risch N (2003) Discovering genotypes underlying human phenotypes: Past successes for mendelian disase, future approaches for complex disease. Nat Genet 33 (Suppl):228-237.
37. Brais B, Bouchard JP, Xie YG, Rochefort DL, Chretien N, Tome FM, Lafreniere RG, Rommens JM, Uyama E, Nohira O, Blumen S, Korczyn AD, Heutink P, Mathieu J, Duranceau A, Codere F, Fardeau M, Rouleau GA (1998) Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 18:164-167.
38. Bross P, Corydon TJ, Andresen BS, Jorgensen MM, Bolund L, Gregersen N (1999) Protein misfolding and degradation in genetic diseases. Hum Mutat 14:186-198.
39. Buckland PR (2003) Polymorphically duplicated genes: Their relevance to phenotypic variation in humans. Ann Med 35:308-315.
40. Burset M, Seledtsov IA, Solovyev VV (2000) Analysis of canonical and non-canonical splice sites in mammalian genomes. Nucleic Acids Res 28:4364-4375.
41. Byers P (2001) Disorders of collagen biosynthesis and structure. In: Scriver CR, Beaudet AL, Valle D et al (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 5241-5286.
42. Cai SP, Eng B, Francombe WH, Olivieri NF, Kendall AG, Waye JS, Chui DH (1992) Two novel beta-thalassemia mutations in the 5' and 3' noncoding regions of the betaglobin gene. Blood 79:1342-1346.
43. Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3:285-298.
44. Caskey CT, Pizzuti A, Fu YH, Fenwick RG Jr, Nelson DL (1992) Triplet repeat mutations in human disease. Science 256:784-789.
45. Cazzola M, Skoda RC (2000) Translational pathophysiology: A novel molecular mechanism of human disease. Blood 95:3280-3288.
46. Challis BG, Pritchard LE, Creemers JW, Delplanque J, Keogh JM, Luan J, Wareham NJ, Yeo GS, Bhattacharyya S, Froguel P, White A, Farooqi IS, O'Rahilly S (2002) A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 11:1997-2004.
47. Chao HK, Hsiao KJ, Su TS (2001) A silent mutation induces exon skipping in the phenylalanine hydroxylase gene in phenylketonuria. Hum Genet 108:14-19.
48. Chelala C, Auffray C (2005) Sex-linked recombination variation and distribution of disease-related genes. Gene 346:29-39.
49. Chen JM, Chuzhanova N, Stenson PD, Ferec C, Cooper DN (2005) Meta-analysis of gross insertions causing human genetic disease: Novel mutational mechanisms and the role of replication slippage. Hum Mutat 25:207-221.
50. Chen JM, Chuzhanova N, Stenson PD, Ferec C, Cooper DN (2005) Complex gene rearrangements caused by serial replication slippage. Hum Mutat 26:125-134.
51. Chen JM, Chuzhanova N, Stenson PD, Ferec C, Cooper DN (2005) Intrachromosomal serial replication slippage in trans gives rise to diverse genomic rearrangements involving inversions. Hum Mutat 26:362-373.
52. Chen JM, Stenson PD, Cooper DN, Ferec C (2005) A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum Genet 117:411-427.
53. Chen JM, Ferec C, Cooper DN (2006) A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: The importance of mRNA secondary structure in assessing the functionality of 3' UTR variants. Hum Genet 120:301-333.
54. Christian SL, Fantes JA, Mewborn SK, Huang B, Ledbetter DH (1999) Large genomic duplicons map to sites of instability in the Prader-Willi/Angelman syndrome chromosome region (15q11-q13). Hum Mol Genet 8:1025-1037.
55. Chuang JH, Li H (2004) Functional bias and spatial organization of genes in mutational hot and cold regions in the human genome. PLoS Biol 2:E29.
56. Chung MY, Ranum LP, Duvick LA, Servadio A, Zoghbi HY, Orr HT (1993) Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I. Nat Genet 5:254-258.
57. Chuzhanova NA, Anassis EJ, Ball EV, Krawczak M, Cooper DN (2003) Meta-analysis of indels causing human genetic disease: Mechanisms of mutagenesis and the role of local DNA sequence complexity. Hum Mutat 21:28-44.
58. Chuzhanova N, Abeysinghe SS, Krawczak M, Cooper DN (2003) Translocation and gross deletion breakpoints in human inherited disease and cancer II: Potential involvement of repetitive sequence elements in secondary structure formation between DNA ends. Hum Mutat 22:245-251.
59. Clegg JB, Weatherall DJ, Milner PF (1971) Haemoglobin Constant Spring-a chain termination mutant? Nature 234:337-340.
60. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibe B, Bouix J, Caiment F, Elsen JM, Eychenne F, Larzul C, Laville E, Meish F, Milenkovic D, Tobin J, Charlier C, Georges M (2006) A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38:813-818.
61. Cogan JD, Phillips JA 3rd, Schenkman SS, Milner RD, Sakati N (1994) Familial growth hormone defi ciency: A model of dominant and recessive mutations affecting a monomeric protein. J Clin Endocrinol Metab 79:1261-1265.
62. Cogan JD, Prince MA, Lekhakula S, Bundey S, Futrakul A, McCarthy EM, Phillips JA 3rd (1997) A novel mechanism of aberrant pre-mRNA splicing in humans. Hum Mol Genet 6:909-912.
63. Collins FS, Stoeckert CJ Jr, Serjeant GR, Forget BG, Weissman SM (1984) G gamma beta+ hereditary persistence of fetal hemoglobin: cosmid cloning and identifi cation of a specific mutation 5' to the G gamma gene. Proc Natl Acad Sci USA 81:4894-4898.
64. Common JE, Di WL, Davies D, Kelsell DP (2004) Further evidence for heterozygote advantage of GJB2 deafness mutations: A link with cell survival. J Med Genet 41:573-575.
65. Conley ME, Partain JD, Norland SM, Shurtleff SA, Kazazian HH Jr (2005) Two independent retrotransposon insertions at the same site within the coding region of BTK. Hum Mutat 25:324-325.
66. Conne B, Stutz A, Vassalli JD (2000) The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nat Med 6:637-641.
67. Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK (2006) A high-resolution survey of deletion polymorphism in the human genome. Nat Genet 38:75-81.
68. Consortium. TIH (2003) The International hapmap project. Nature 426:789-796.
69. Conway GS, Hettiarachchi S, Murray A, Jacobs PA (1995) Fragile X premutations in familial premature ovarian failure. Lancet 346:309-310.
70. Cooper DN (1983) Eukaryotic DNA methylation. Hum Genet 64:315-333.
71. Cooper DN (1999) Human gene evolution. Bios Scientific, Oxford.
72. Cooper DN, Krawczak M (1991) Mechanisms of insertional mutagenesis in human genes causing genetic disease. Hum Genet 87:409-415.
73. Cooper DN, Krawczak M (1993) Human gene mutation. Bios Scientific, Oxford.
74. Cooper DN, Youssoufian H (1988) The CpG dinucleotide and human genetic disease. Hum Genet 78:151-155.
75. Cooper DN, Smith BA, Cooke HJ, Niemann S, Schmidtke J (1985) An estimate of unique DNA sequence heterozygosity in the human genome. Hum Genet 69:201-205.
76. Cotton RG, Scriver CR (1998) Proof of "disease causing" mutation. Hum Mutat 12:1-3.
77. Coutinho G, Xie J, Du L, Brusco A, Krainer AR, Gatti RA (2005) Functional signifi cance of a deep intronic mutation in the ATM gene and evidence for an alternative exon 28a. Hum Mutat 25:118-124.
78. Crawford DC, Akey DT, Nickerson DA (2005) The patterns of natural variation in human genes. Annu Rev Genomics Hum Genet 6:287-312.
79. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, Bisceglia L, Zelante L, Nagaraja R, Porcu S, Ristaldi MS, Marzella R, Rocchi M, Nicolino M, Lienhardt-Roussie A, Nivelon A, Verloes A, Schlessinger D, Gasparini P, Bonneau D, Cao A, Pilia G (2001) The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27:159-166.
80. Crossley M, Brownlee GG (1990) Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature 345:444-446.
81. Crow JF (2000) The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet 1:40-47.
82. Datz C, Haas T, Rinner H, Sandhofer F, Patsch W, Paulweber B (1998) Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: A protective role against iron deficiency? Clin Chem 44:2429-2432.
83. Davis BM, McCurrach ME, Taneja KL, Singer RH, Housman DE (1997) Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci USA 94:7388-7393.
84. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268:10739-10745.
85. De Gobbi M, Viprakasit V, Hughes JR, Fisher C, Buckle VJ, Ayyub H, Gibbons RJ, Vernimmen D, Yoshinaga Y, de Jong P, Cheng JF, Rubin EM, Wood WG, Bowden D, Higgs DR (2006) A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science 312: 1215-1217.
86. Deininger PL, Batzer MA (1999) Alu repeats and human disease. Mol Genet Metab 67:183-193.
87. De Klein A, Riegman PH, Bijlsma EK, Heldoorn A, Muijtjens M, den Bakker MA, Avezaat CJ, Zwarthoff EC (1998) A G-A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofi bromatosis 2. Hum Mol Genet 7:393-398.
88. de Kok YJ, Vossenaar ER, Cremers CW, Dahl N, Laporte J, Hu LJ, Lacombe D, Fischel-Ghodsian N, Friedman RA, Parnes LS, Thorpe P, Bitner-Glindzicz M, Pander HJ, Heilbronner H, Graveline J, den Dunnen JT, Brunner HG, Ropers HH, Cremers FP (1996) Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4. Hum Mol Genet 5:1229-1235.
89. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G et al (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162-165.
90. de Mollerat XJ, Gurrieri F, Morgan CT, Sangiorgi E, Everman DB, Gaspari P, Amiel J, Bamshad MJ, Lyle R, Blouin JL, Allanson JE, Le Marec B, Wilson M, Braverman NE, Radhakrishna U, Delozier-Blanchet C, Abbott A, Elghouzzi V, Antonarakis S, Stevenson RE, Munnich A, Neri G, Schwartz CE (2003) A genomic rearrangement resulting in a tandem duplication is associated with split hand-split foot malformation 3 (SHFM3) at 10q24. Hum Mol Genet 12:1959-1971.
91. den Dunnen JT, Antonarakis SE (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121-124.
92. den Dunnen, JT, Bakker E, Breteler EG, Pearson PL, van Ommen, GJ (1987) Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by fi eld inversion gels. Nature 329:640-642.
93. Dermitzakis ET, Reymond A, Lyle R, Scamuffa N, Ucla C, Deutsch S, Stevenson BJ, Flegel V, Bucher P, Jongeneel CV, Antonarakis SE (2002) Numerous potentially functional but non-genic conserved sequences on human chromosome 21. Nature 420:578-582.
94. Dermitzakis ET, Reymond A, Antonarakis SE (2005) Conserved non-genic sequences - An unexpected feature of mammalian genomes. Nat Rev Genet 6:151-157.
95. Dietz HC, Valle D, Francomano CA, Kendzior RJ Jr, Pyeritz RE, Cutting GR (1993) The skipping of constitutive exons in vivo induced by nonsense mutations. Science 259: 680-683.
96. Dobyns WB, Filauro A, Tomson BN, Chan AS, Ho AW, Ting NT, Oosterwijk JC, Ober C (2004) Inheritance of most X-linked traits is not dominant or recessive, just X-linked. Am J Med Genet 129:136-143.
97. Dombroski B, Mathias S, Nanthakumar E, Scott A, Kazazian H Jr (1991) Isolation of an active human transposable element. Science 254:1805-1808.
98. Dorschner MO, Sybert VP, Weaver M, Pletcher BA, Stephens K (2000) NF1 microdeletion breakpoints are clustered at fl anking repetitive sequences. Hum Mol Genet 9:35-46.
99. Driscoll DJ, Migeon BR (1990) Sex difference in methylation of single-copy genes in human meiotic germ cells: Implications for X chromosome inactivation, parental imprinting, and origin of CpG mutations. Somat Cell Mol Genet 16:267-282.
100. Driscoll MC, Dobkin CS, Alter BP (1989) Gamma delta beta-thalassemia due to a de novo mutation deleting the 5' beta-globin gene activation-region hypersensitive sites. Proc Natl Acad Sci USA 86:7470-7474.
101. Economou EP, Bergen AW, Warren AC, Antonarakis SE (1990) The polydeoxyadenylate tract of Alu repetitive elements is polymorphic in the human genome. Proc Natl Acad Sci USA 87:2951-2954.
102. Edelmann L, Pandita RK, Morrow BE (1999) Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. Am J Hum Genet 64:1076-1086.
103. Editorial (2005) A haplotype map of the human genome. Nature 437:1299-1320.
104. Efstratiadis A, Posakony JW, Maniatis T, Lawn RM, O'Connell C, Spritz RA, DeRiel JK, Forget BG, Weissman SM, Slightom JL, Blechl AE, Smithies O, Baralle FE, Shoulders CC, Proudfoot NJ (1980) The structure and evolution of the human beta-globin gene family. Cell 21:653-668.
105. Eikenboom JC, Vink T, Briet E, Sixma JJ, Reitsma PH (1994) Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence. Proc Natl Acad Sci USA 91:2221-2224.
106. Embury SH, Miller JA, Dozy AM, Kan YW, Chan V, Todd D (1980) Two different molecular organizations account for the single alpha-globin gene of the alpha-thalassemia-2 genotype. J Clin Invest 66:1319-1325.
107. Erickson RP (2003) Somatic gene mutation and human disease other than cancer. Mutat Res 543:125-136.
108. Eyal N, Wilder S, Horowitz M (1990) Prevalent and rare mutations among Gaucher patients. Gene 96:277-283.
109. Fantes J, Redeker B, Breen M, Boyle S, Brown J, Fletcher J, Jones S, Bickmore W, Fukushima Y, Mannens M, Danes S, van Heyningen V, Hanson I (1995) Aniridia-associated cytogenetic rearrangements suggest that a position effect may cause the mutant phenotype. Hum Mol Genet 4:415-422.
110. Faustino NA, Cooper TA (2003) Pre-mRNA splicing and human disease. Genes Dev 17:419-437.
111. Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, Reinisch W, Teml A, Schwab M, Lichter P, Radlwimmer B, Stange EF (2006) A chromosome 8 gene-cluster polymorphism with low human betadefensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 79:439-448.
112. Ferrer-Costa C, Orozco M, de la Cruz X (2002) Characterization of disease-associated single amino acid polymorphisms in terms of sequence and structure properties. J Mol Biol 315:771-786.
113. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1038.
114. Flint J, Harding RM, Clegg JB, Boyce AJ (1993) Why are some genetic diseases common? Distinguishing selection from other processes by molecular analysis of globin gene variants. Hum Genet 91:91-117.
115. Francke U (1999) Williams-Beuren syndrome: genes and mechanisms. Hum Mol Genet 8:1947-1954.
116. Frank SA, Nowak MA (2004) Problems of somatic mutation and cancer. Bioessays 26:291-299.
117. Frisch A, Colombo R, Michaelovsky E, Karpati M, Goldman B, Peleg L (2004) Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis. Hum Genet 114:366-376.
118. Frischmeyer PA, Dietz HC (1999) Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 8:1893-1900.
119. Fu Y-H, Kuhl D, Pizzuti A, Pieretti M, Sutcliffe JS, Richards CS, Verkerk AJMH, Holden J, Fenwick RJ, Warren ST, Oostra BA, Nelson DL, Caskey CT (1991) Variation of the CGG repeat at the Fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-1058.
120. Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengard JH, Salomaa V, Vartiainen E, Perola M, Boerwinkle E, Sing CF (2000) Apolipoprotein E variation at the sequence haplotype level: Implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet 67:881-900.
121. Gabellini D, Green MR, Tupler R (2002) Inappropriate Gene Activation in FSHD. A repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110:339-348.
122. Gabriel SE, Brigman KN, Koller BH, Boucher RC, Stutts MJ (1994) Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266: 107-109.
123. Gao L, Zhang J (2003) Why are some human disease-associated mutations fixed in mice? Trends Genet 19:678-681.
124. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, Kulozik AE (2001) Increased efficiency of mRNA 3' end formation: A new genetic mechanism contributing to hereditary thrombophilia. Nat Genet 28:389-392.
125. Girelli D, Corrocher R, Bisceglia L, Olivieri O, De Franceschi L, Zelante L, Gasparini P (1995) Molecular basis for the recently described hereditary hyperferritinemiacataract syndrome: A mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation"). Blood 86:4050-4053.
126. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, O'Connell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK (2005) The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 307:1434-1440.
127. Goossens M, Dozy AM, Embury SH, Zachariades Z, Hadjiminas MG, Stamatoyannopoulos G, Kan YW (1980) Triplicated alpha-globin loci in humans. Proc Natl Acad Sci USA 77:518-521.
128. Goriely A, McVean GA, Rojmyr M, Ingemarsson B, Wilkie AO (2003) Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 301:643-646.
129. Goriely A, McVean GA, van Pelt AM, O'Rourke AW, Wall SA, de Rooij DG, Wilkie AO (2005) Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia. Proc Natl Acad Sci USA 102:6051-6056.
130. Gorlach A, Lee PL, Roesler J, Hopkins PJ, Christensen B, Green ED, Chanock SJ, Curnutte JT (1997) A p47-phox pseudogene carries the most common mutation causing p47-phox- defi cient chronic granulomatous disease. J Clin Invest 100:1907-1918.
131. Gorlov IP, Gorlova OY, Frazier ML, Amos CI (2003) Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers. Am J Hum Genet 73:1157-1161.
132. Green H, Djian P (1992) Consecutive actions of different gene-altering mechanisms in the evolution of involucrin. Mol Biol Evol 9:977-1017.
133. Green P, Ewing B, Miller W, Thomas PJ, Green ED (2003) Transcription-associated mutational asymmetry in mammalian evolution. Nat Genet 33:514-517.
134. Greenblatt MS, Grollman AP, Harris CC (1996) Deletions and insertions in the p53 tumor suppressor gene in human cancers: confi rmation of the DNA polymerase slippage/misalignment model. Cancer Res 56:2130-2136.
135. Gregersen N, Bross P, Jorgensen MM, Corydon TJ, Andresen BS (2000) Defective folding and rapid degradation of mutant proteins is a common disease mechanism in genetic disorders. J Inherit Metab Dis 23:441-447.
136. Grimm T, Meng G, Liechti-Gallati S, Bettecken T, Muller CR, Muller B (1994) On the origin of deletions and point mutations in Duchenne muscular dystrophy: Most deletions arise in oogenesis and most point mutations result from events in spermatogenesis. J Med Genet 31:183-186.
137. Grosveld F, van Assendelft GB, Greaves DR, Kollias G (1987) Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell 51:975-985.
138. Guioli S, Incerti B, Zanaria E, Bardoni B, Franco B, Taylor K, Ballabio A, Camerino G (1992) Kallmann syndrome due to a translocation resulting in an X/Y fusion gene. Nat Genet 1:337-340.
139. Hall JG (1988) Review and hypotheses: Somatic mosaicism: observations related to clinical genetics. Am J Hum Genet 43:355-363.
140. Harland M, Mistry S, Bishop DT, Bishop JA (2001) A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum Mol Genet 10:2679-2686.
141. Harper PS, Harley HG, Reardon W, Shaw DJ (1992) Anticipation in myotonic dystrophy: New light on an old problem. Am J Hum Genet 51:10-16.
142. Hewitt JE, Lyle R, Clark LN, Vallely EM, Wright TJ, Wijmenga C, van Deutekom JCT, Francis F, Sharpe PT, Hofker M, Frants RR, Williamson R (1994) Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 3:1287-1295.
143. Higuchi M, Wong C, Kochhan L, Olek K, Aronis S, Kasper CK, Kazazian HH Jr, Antonarakis SE (1990) Characterization of mutations in the factor VIII gene by direct sequencing of amplifi ed genomic DNA. Genomics 6:65-71.
144. Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger DG, Frazer KA, Cox DR (2005) Whole-genome patterns of common DNA variation in three human populations. Science 307:1072-1079.
145. Hinds DA, Kloek AP, Jen M, Chen X, Frazer KA (2006) Common deletions and SNPs are in linkage disequilibrium in the human genome. Nat Genet 38:82-85.
146. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4:45-61.
147. Hitchins M, Williams R, Cheong K, Halani N, Lin VA, Packham D, Ku S, Buckle A, Hawkins N, Burn J, Gallinger S, Goldblatt J, Kirk J, Tomlinson I, Scott R, Spigelman A, Suter C, Martin D, Suthers G, Ward R (2005) MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology 129:1392-1399.
148. Ho PJ, Rochette J, Fisher CA, Wonke B, Jarvis MK, Yardumian A, Thein SL (1996) Moderate reduction of beta-globin gene transcript by a novel mutation in the 5' untranslated region: A study of its interaction with other genotypes in two families. Blood 87:1170-1178.
149. Hogenauer C, Santa Ana CA, Porter JL, Millard M, Gelfand A, Rosenblatt RL, Prestidge CB, Fordtran JS (2000) Active intestinal chloride secretion in human carriers of cystic fi brosis mutations: An evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am J Hum Genet 67:1422-1427.
150. Housman D (1995) Gain of glutamines, gain of function? Nat Genet 10:3-4.
151. Hu XY, Ray PN, Murphy EG, Thompson MW, Worton RG (1990) Duplicational mutation at the Duchenne muscular dystrophy locus: Its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet 46:682-695.
152. Huang H, Winter EE, Wang H, Weinstock KG, Xing H, Goodstadt L, Stenson PD, Cooper DN, Smith D, Alba MM, Ponting CP, Fechtel K (2004) Evolutionary conservation and selection of human disease gene orthologs in the rat and mouse genomes. Genome Biol 5:R47.
153. Hurles M (2005) How homologous recombination generates a mutable genome. Hum Genomics 2:179-186.
154. Hurst LD, Ellegren H (1998) Sex biases in the mutation rate. Trends Genet 14:446-452.
155. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S et al (1998) Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702-705.
156. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C (2004) Detection of largescale variation in the human genome. Nat Genet 36: 949-951.
157. Inacio A, Silva AL, Pinto J, Ji X, Morgado A, Almeida F, Faustino P, Lavinha J, Liebhaber SA, Romao L (2004) Nonsense mutations in close proximity to the initiation codon fail to trigger full nonsense-mediated mRNA decay. J Biol Chem 279:32170-32180.
158. Ingram VM (1956) A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature 178:792-794.
159. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM (1997) A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99:1786-1797.
160. Inoue K, Khajavi M, Ohyama T, Hirabayashi S, Wilson J, Reggin JD, Mancias P, Butler IJ, Wilkinson MF, Wegner M, Lupski JR (2004) Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet 36:361-369.
161. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558-561.
162. Jacobson EM, Concepcion E, Oashi T, Tomer Y (2005) A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: A case for translational pathophysiology. Endocrinology 146:2684-2691.
163. Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R, Berry-Kravis E, Brown WT, Schaeffer S, Kissel J, Tassone F, Hagerman PJ (2003) Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates. Am J Hum Genet 72:869-878.
164. Jeffreys AJ, Wilson V, Thein SL (1985) Hypervariable 'minisatellite' regions in human DNA. Nature 314:67-73.
165. Jeffreys AJ, Neumann R, Wilson V (1990) Repeat unit sequence variation in minisatellites: A novel source of DNA polymorphism for studying variation and mutation by single molecule analysis. Cell 60:473-485.
166. Jego N, Thomas G, Hamelin R (1993) Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers. Oncogene 8:209-213.
167. Jennings MW, Jones RW, Wood WG, Weatherall DJ (1985) Analysis of an inversion within the human beta globin gene cluster. Nucleic Acids Res 13:2897-2907.
168. Ji Y, Eichler EE, Schwartz S, Nicholls RD (2000) Structure of chromosomal duplicons and their role in mediating human genomic disorders. Genome Res 10:597-610.
169. Juyal RC, Figuera LE, Hauge X, Elsea SH, Lupski JR, Greenberg F, Baldini A, Patel PI (1996) Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients. Am J Hum Genet 58:998-1007.
170. Kajiwara K, Berson EL, Dryja TP (1994) Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science 264:1604-1608.
171. Kang S, Ohshima K, Jaworski A, Wells RD (1996) CTG triplet repeats from the myotonic dystrophy gene are expanded in Escherichia coli distal to the replication origin as a single large event. J Mol Biol 258:543-547.
172. Karathanasis SK, Ferris E, Haddad IA (1987) DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci USA 84:7198-7202.
173. Katsanis N, Ansley SJ, Badano JL, Eichers ER, Lewis RA, Hoskins BE, Scambler PJ, Davidson WS, Beales PL, Lupski JR (2001) Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science 293:2256-2259.
174. Kazazian HH Jr (1998) Mobile elements and disease. Curr Opin Genet Dev 8:343-350.
175. Kazazian HH Jr, Wong C, Youssoufi an H, Scott AF, Phillips DG, Antonarakis SE (1988) Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 332:164-166.
176. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB (1995) Sequence and expression of a candidate for the human Secretor blood group alpha(1, 2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the nonsecretor phenotype. Biol Chem 270:4640-4649.
177. Kerlin BA, Yan SB, Isermann BH, Brandt JT, Sood R, Basson BR, Joyce DE, Weiler H, Dhainaut JF (2003) Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. Blood 102:3085-3092.
178. Ketterling RP, Ricke DO, Wurster MW, Sommer SS (1993) Deletions with inversions: report of a mutation and review of the literature. Hum Mutat 2:53-57.
179. Kim HJ, Nam SH, Kim HJ, Park HS, Ryoo HM, Kim SY, Cho TJ, Kim SG, Bae SC, Kim IS, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Choi JY (2006) Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype. J Cell Physiol 207: 114-122.
180. Kleinjan DJ, van Heyningen V (1998) Position effect in human genetic disease. Hum Mol Genet 7:1611-1618.
181. Kleinjan DA, van Heyningen V (2005) Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 76:8-32.
182. Knebelmann B, Forestier L, Drouot L, Quinones S, Chuet C, Benessy F, Saus J, Antignac C (1995) Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum Mol Genet 4:675-679.
183. Koivisto UM, Palvimo JJ, Janne OA, Kontula K (1994) A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc Natl Acad Sci USA 91:10526-10530.
184. Kolomietz E, Meyn MS, Pandita A, Squire JA (2002) The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 35:97-112.
185. Kondrashov AS (2003) Direct estimates of human per nucleotide mutation rates at 20 loci causing Mendelian diseases. Hum Mutat 21:12-27.
186. Kondrashov AS, Rogozin IB (2004) Context of deletions and insertions in human coding sequences. Hum Mutat 23:177-185.
187. Kondrashov FA, Ogurtsov AY, Kondrashov AS (2004) Bioinformatical assay of human gene morbidity. Nucleic Acids Res 32:1731-1737.
188. Koolen DA, Vissers LE, Pfundt R, de Leeuw N, Knight SJ, Regan R, Kooy RF, Reyniers E, Romano C, Fichera M, Schinzel A, Baumer A, Anderlid BM, Schoumans J, Knoers NV, van Kessel AG, Sistermans EA, Veltman JA, Brunner HG, de Vries BB (2006) A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat Genet 38:999-1001.
189. Kornreich R, Bishop DF, Desnick RJ (1990) a-galactosidase A gene rearrangements causing Fabry disease. J Biol Chem 265:9319-9326.
190. Kozak M (1984) Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res 12:857-872.
191. Kozak M (1991) Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem 266:19867-19870.
192. Kozak M (2002) Emerging links between initiation of translation and human diseases. Mamm Genome 13:401-410.
193. Krawczak M, Cooper DN (1991) Gene deletions causing human genetic disease: Mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet 86:425-441.
194. Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41-54.
195. Krawczak M, Ball EV, Cooper DN (1998) Neighboringnucleotide effects on the rates of germ-line single-basepair substitution in human genes. Am J Hum Genet 63:474-488.
196. Krawczak M, Chuzhanova NA, Stenson PD, Johansen BN, Ball EV, Cooper DN (2000) Changes in primary DNA sequence complexity influence the phenotypic consequences of mutations in human gene regulatory regions. Hum Genet 107:362-365.
197. Krawczak M, Thomas NS, Hundrieser B, Mort M, Wittig M, Hampe J, Cooper DN (2006) Single base-pair substitutions in exon-intron junctions of human genes: Nature, distribution, and consequences for mRNA splicing. Hum Mutat 28:150-158.
198. Kunkel TA (1985) The mutational specifi city of DNA polymerases-alpha and -gamma during in vitro DNA synthesis. J Biol Chem 260:12866-12874.
199. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, Vogelstein B (1997) Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 17:79-83.
200. Lakich D, Kazazian HH Jr, Antonarakis SE, Gitschier J (1993) Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet 5:236-241.
201. Lalioti MD, Scott HS, Buresi C, Rossier C, Bottani A, Morris MA, Malafosse A, Antonarakis SE (1997) Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 386:847-851.
202. Lalioti MD, Scott HS, Antonarakis SE (1999) Altered spacing of promoter elements due to the dodecamer repeat expansion contributes to reduced expression of the cystatin B gene in EPM1. Hum Mol Genet 8:1791-1798.
203. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K et al (2001) Initial sequencing and analysis of the human genome. Nature 409:860-921.
204. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom- Lahti M et al (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215-1225.
205. Lehrman MA, Goldstein JL, Russell DW, Brown MS (1987) Duplication of seven exons in LDL receptor gene caused by Alu-Alu recombination in a subject with familial hypercholesterolemia. Cell 48:827-835.
206. Le Marechal, C, Masson E, Chen JM, Morel F, Ruszniewski P, Levy P, Ferec C (2006) Hereditary pancreatitis caused by triplication of the trypsinogen locus. Nat Genet 38:1372-1374.
207. Lettice LA, Horikoshi T, Heaney SJ, van Baren MJ, van der Linde HC, Breedveld GJ, Joosse M, Akarsu N, Oostra BA, Endo N, Shibata M, Suzuki M, Takahashi E, Shinka T, Nakahori Y, Ayusawa D, Nakabayashi K, Scherer SW, Heutink P, Hill RE, Noji S (2002) Disruption of a longrange cis-acting regulator for Shh causes preaxial polydactyly. Proc Natl Acad Sci USA 99:7548-7553.
208. Li X, Scaringe WA, Hill KA, Roberts S, Mengos A, Careri D, Pinto MT, Kasper CK, Sommer SS (2001) Frequency of recent retrotransposition events in the human factor IX gene. Hum Mutat 17:511-519.
209. Liebhaber SA, Griese EU, Weiss I, Cash FE, Ayyub H, Higgs DR, Horst J (1990) Inactivation of human alphaglobin gene expression by a de novo deletion located upstream of the alpha-globin gene cluster. Proc Natl Acad Sci USA 87:9431-9435.
210. Linton MF, Pierotti V, Young SG (1992) Reading-frame restoration with an apolipoprotein B gene frameshift mutation. Proc Natl Acad Sci USA 89:11431-11435.
211. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864-867.
212. Litt M, Luty JA (1989) A hypervariable microsatellite revealed by in vitro amplification of a dinucleotide repeat within the cardiac muscle actin gene. Am J Hum Genet 44:397-401.
213. Liu HX, Cartegni L, Zhang MQ, Krainer AR (2001) A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 27:55-58.
214. Loeb LA, Kunkel TA (1982) Fidelity of DNA synthesis. Annu Rev Biochem 51:429-457.
215. Loots GG, Kneissel M, Keller H, Baptist M, Chang J, Collette NM, Ovcharenko D, Plajzer-Frick I, Rubin EM (2005) Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease. Genome Res 15:928-935.
216. Lopez-Bigas N, Ouzounis CA (2004) Genome-wide identification of genes likely to be involved in human genetic disease. Nucleic Acids Res 32:3108-3114.
217. Majewski J (2003) Dependence of mutational asymmetry on gene-expression levels in the human genome. Am J Hum Genet 73:688-692.
218. Mandel JL (1993) Questions of expansion. Nat Genet 4:8-9.
219. Maquat LE (2004) Nonsense-mediated mRNA decay: Splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 5:89-99.
220. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B et al (1995) Inactivation of the type II TGFbeta receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338.
221. Matsuura T, Yamagata T, Burgess DL, Rasmussen A, Grewal RP, Watase K, Khajavi M, McCall AE, Davis CF, Zu L, Achari M, Pulst SM, Alonso E, Noebels JL, Nelson DL, Zoghbi HY, Ashizawa T (2000) Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 26:191-194.
222. McCarroll SA, Hadnott TN, Perry GH, Sabeti PC, Zody MC, Barrett JC, Dallaire S, Gabriel SB, Lee C, Daly MJ, Altshuler DM (2006) Common deletion polymorphisms in the human genome. Nat Genet 38:86-92.
223. McNaughton JC, Cockburn DJ, Hughes G, Jones WA, Laing NG, Ray PN, Stockwell PA, Petersen GB (1998) Is gene deletion in eukaryotes sequence-dependent? A study of nine deletion junctions and nineteen other deletion breakpoints in intron 7 of the human dystrophin gene. Gene 222:41-51.
224. McVey JH, Michaelides K, Hansen LP, Ferguson-Smith M, Tilghman S, Krumlauf R, Tuddenham EG (1993) A G->A substitution in an HNF I binding site in the human alpha-fetoprotein gene is associated with hereditary persistence of alpha-fetoprotein (HPAFP). Hum Mol Genet 2:379-384.
225. Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, Campbell T, Uphill JB, Goldstein D, Alpers M, Fisher EM, Collinge J (2003) Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300:640-643.
226. Mehdi H, Manzi S, Desai P, Chen Q, Nestlerode C, Bontempo F, Strom SC, Zarnegar R, Kamboh MI (2003) A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. Eur J Biochem 270: 230-238.
227. Millar DS, Lewis MD, Horan M, Newsway V, Easter TE, Gregory JW, Fryklund L, Norin M, Crowne EC, Davies SJ, Edwards P, Kirk J, Waldron K, Smith PJ, Phillips JA 3rd, Scanlon MF, Krawczak M, Cooper DN, Procter AM (2003) Novel mutations of the growth hormone 1 (GH1) gene disclosed by modulation of the clinical selection criteria for individuals with short stature. Hum Mutat 21:424-440.
228. Miller MP, Kumar S (2001) Understanding human disease mutations through the use of interspecifi c genetic variation. Hum Mol Genet 10:2319-2328.
229. Miller MP, Parker JD, Rissing SW, Kumar S (2003) Quantifying the intragenic distribution of human disease mutations. Ann Hum Genet 67:567-579.
230. Minegishi Y, Coustan-Smith E, Wang YH, Cooper MD, Campana D, Conley ME (1998) Mutations in the human lambda5/14.1 gene result in B cell defi ciency and agammaglobulinemia. J Exp Med 187:71-77.
231. Mitchell GA, Labuda D, Fontaine G, Saudubray JM, Bonnefont JP, Lyonnet S, Brody LC, Steel G, Obie C, Valle D (1991) Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase: A role for Alu elements in human mutation. Proc Natl Acad Sci USA 88:815-819.
232. Mockenhaupt FP, Mandelkow J, Till H, Ehrhardt S, Eggelte TA, Bienzle U (2003) Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency. Trop Med Int Health 8:118-124.
233. Moi P, Loudianos G, Lavinha J, Murru S, Cossu P, Casu R, Oggiano L, Longinotti M, Cao A, Pirastu M (1992) Deltathalassemia due to a mutation in an erythroid-specifi c binding protein sequence 3' to the delta-globin gene. Blood 79:512-516.
234. Mooers BH, Logue JS, Berglund JA (2005) The structural basis of myotonic dystrophy from the crystal structure of CUG repeats. Proc Natl Acad Sci USA 102:16626-16631.
235. Morell R, Spritz RA, Ho L, Pierpont J, Guo W, Friedman TB, Asher JH Jr (1997) Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA). Hum Mol Genet 6:659-664.
236. Motulsky AG (1995) Jewish diseases and origins. Nat Genet 9:99-101.
237. Muragaki Y, Mundlos S, Upton J, Olsen BR (1996) Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science 272:548-551.
238. Muratani K, Hada T, Yamamoto Y, Kaneko T, Shigeto Y, Ohue T, Furuyama J, Higashino K (1991) Inactivation of the cholinesterase gene by Alu insertion: Possible mechanism for human gene transposition. Proc Natl Acad Sci USA 88:11315-11319.
239. Nathans J, Piantanida TP, Eddy RL, Shows TB, Hogness DS (1986) Molecular genetics of inherited variation in human color vision. Science 232:203-210.
240. Naylor JA, Green PM, Rizza CR, Giannelli F (1993) Analysis of factor VIII mRNA reveals defects in everyone of 28 haemophilia A patients. Hum Mol Genet 2:11-17.
241. Neitz M, Neitz J, Grishok A (1995) Polymorphism in the number of genes encoding long-wavelength-sensitive cone pigments among males with normal color vision. Vision Res 35:2395-2407.
242. Nicholls RD, Fischel-Ghodsian N, Higgs DR (1987) Recombination at the human alpha-globin gene cluster: Sequence features and topological constraints. Cell 49:369-378.
243. Nichols WC, Ginsburg D (1997) von Willebrand disease. Medicine (Baltimore) 76:1-20.
244. Nickerson DA, Taylor SL, Weiss KM, Clark AG, Hutchinson RG, Stengard J, Salomaa V, Vartiainen E, Boerwinkle E, Sing CF (1998) DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet 19:233-240.
245. Nishihara S, Narimatsu H, Iwasaki H, Yazawa S, Akamatsu S, Ando T, Seno T, Narimatsu I (1994) Molecular genetic analysis of the human Lewis histo-blood group system. J Biol Chem 269:29271-29278.
246. Oldenburg J, Rost S, El-Maarri O, Leuer M, Olek K, Muller CR, Schwaab R (2000) De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism. Blood 96:2905-2906.
247. Orkin SH, Kazazian HH Jr, Antonarakis SE, Ostrer H, Goff SC, Sexton JP (1982) Abnormal RNA processing due to the exon mutation of beta E-globin gene. Nature 300:768-769.
248. Orkin SH, Antonarakis SE, Kazazian HH Jr (1984) Base substitution at position -88 in a beta-thalassemic globin gene. Further evidence for the role of distal promoter element ACACCC. J Biol Chem 259:8679-8681.
249. Orkin SH, Cheng TC, Antonarakis SE, Kazazian HH Jr (1985) Thalassemia due to a mutation in the cleavagepolyadenylation signal of the human beta-globin gene. EMBO J 4:453-456.
250. Oron-Karni V, Filon D, Rund D, Oppenheim A (1997) A novel mechanism generating short deletion/insertions following slippage is suggested by a mutation in the human alpha2-globin gene. Hum Mol Genet 6:881-885.
251. Ostertag EM, Kazazian HH Jr (2001) Biology of mammalian L1 retrotransposons. Annu Rev Genet 35:501-538.
252. Ostrer H (2001) A genetic profile of contemporary Jewish populations. Nat Rev Genet 2:891-898.
253. Owen MC, Brennan SO, Lewis JH, Carrell RW (1983) Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N Engl J Med 309:694-698.
254. Ozisik G, Mantovani G, Achermann JC, Persani L, Spada A, Weiss J, Beck-Peccoz P, Jameson JL (2003) An alternate translation initiation site circumvents an amino-terminal DAX1 nonsense mutation leading to a mild form of X-linked adrenal hypoplasia congenita. J Clin Endocrinol Metab 88:417-423.
255. Pagani F, Baralle FE (2004) Genomic variants in exons and introns: Identifying the splicing spoilers. Nat Rev Genet 5:389-396.
256. Pagani F, Buratti E, Stuani C, Bendix R, Dork T, Baralle FE (2002) A new type of mutation causes a splicing defect in ATM. Nat Genet 30:426-429.
257. Pagani F, Raponi M, Baralle FE (2005) Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. Proc Natl Acad Sci USA 102:6368-6372.
258. Pakula AA, Sauer RT (1989) Genetic analysis of protein stability and function. Annu Rev Genet 23:289-310.
259. Paoloni-Giacobino A, Rossier C, Papasavvas MP, Antonarakis SE (2001) Frequency of replication/transcription errors in (A)/(T) runs of human genes. Hum Genet 109:40-47.
260. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD et al (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625-1629.
261. Parchi P, Petersen RB, Chen SG, Autilio-Gambetti L, Capellari S, Monari L, Cortelli P, Montagna P, Lugaresi E, Gambetti P (1998) Molecular pathology of fatal familial insomnia. Brain Pathol 8:539-548.
262. Pascoe L, Jeunemaitre X, Lebrethon MC, Curnow KM, Gomez-Sanchez CE, Gasc JM, Saez JM, Corvol P (1995) Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J Clin Invest 96:2236-2246.
263. Patel PI, Roa BB, Welcher AA, Schoener-Scott R, Trask BJ, Pentao L, Snipes GJ, Garcia CA, Francke U, Shooter EM, Lupski JR, Suter U (1992) The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie- Tooth disease type 1A. Nat Genet 1:159-165.
264. Pearson CE, Nichol Edamura K, Cleary JD (2005) Repeat instability: Mechanisms of dynamic mutations. Nat Rev Genet 6:729-742.
265. Pentao L, Wise CA, Chinault AC, Patel PI, Lupski JR (1992) Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences fl anking the 1.5 Mb monomer unit. Nat Genet 2:292-300.
266. Perkins AC, Sharpe AH, Orkin SH (1995) Lethal betathalassaemia in mice lacking the erythroid CACCCtranscription factor EKLF. Nature 375:318-322.
267. Petrov A, Pirozhkova I, Carnac G, Laoudj D, Lipinski M, Vassetzky YS (2006) Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts. Proc Natl Acad Sci USA 103:6982-6987.
268. Pfeifer D, Kist R, Dewar K, Devon K, Lander ES, Birren B, Korniszewski L, Back E, Scherer G (1999) Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9: evidence for an extended control region. Am J Hum Genet 65:111-124.
269. Pier GB (2000) Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. Proc Natl Acad Sci USA 97: 8822-8828.
270. Pirastu M, Saglio G, Chang JC, Cao A, Kan YW (1984) Initiation codon mutation as a cause of alpha thalassemia. J Biol Chem 259:12315-12317.
271. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703.
272. Rabbitts TH (1994) Chromosomal translocations in human cancer. Nature 372:143-149.
273. Rebbeck TR (1997) Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6:733-743.
274. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H et al (2006) Global variation in copy number in the human genome. Nature 444:444-454.
275. Reich DE, Schaffner SF, Daly MJ, McVean G, Mullikin JC, Higgins JM, Richter DJ, Lander ES, Altshuler D (2002) Human genome sequence variation and the infl uence of gene history, mutation and recombination. Nat Genet 32:135-142.
276. Reiter LT, Hastings PJ, Nelis E, De Jonghe P, Van Broeckhoven C, Lupski JR (1998) Human meiotic recombination products revealed by sequencing a hotspot for homologous strand exchange in multiple HNPP deletion patients. Am J Hum Genet 62:1023-1033.
277. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346.
278. Risch N, Tang H, Katzenstein H, Ekstein J (2003) Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection. Am J Hum Genet 72:812-822.
279. Rosenthal A, Jouet M, Kenwrick S (1992) Aberrant splicing of neural cell adhesion molecule L1 mRNA in a family with X-linked hydrocephalus. Nat Genet 2:107-112.
280. Rossiter JP, Young M, Kimberland ML, Hutter P, Ketterling RP, Gitschier J, Horst J, Morris MA, Schaid DJ, de Moerloose P, Sommer SS, Kazazian HH, Antonarakis SE (1994) Factor VIII gene inversions causing severe haemophilia A originate almost exclusively in male germ cells. Hum Mol Genet 3:1035-1039.
281. Roth DB, Wilson JH (1986) Nonhomologous recombination in mammalian cells: role for short sequence homologies in the joining reaction. Mol Cell Biol 6: 4295-4304.
282. Rousseau F, Heitz D, Mandel JL (1992) The unstable and methylatable mutations causing the fragile X syndrome. Hum Mutat 1:91-96.
283. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, Dubas F, Frebourg T, Campion D (2006) APP locus duplication causes autosomal dominant earlyonset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24-26.
284. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N et al (1995) Natural selection of hemi- And heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376:246-249.
285. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S et al (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409:928-933.
286. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N (1985) Enzymatic amplifi cation of betaglobin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-1354.
287. Santisteban I, Arredondo-Vega FX, Kelly S, Loubser M, Meydan N, Roifman C, Howell PL, Bowen T, Weinberg KI, Schroeder ML et al (1995) Three new adenosine deaminase mutations that defi ne a splicing enhancer and cause severe and partial phenotypes: Implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. Hum Mol Genet 4:2081-2087.
288. Savkur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, Ranum LP, Day JW (2004) Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 74:1309-1313.
289. Schmucker B, Krawczak M (1997) Meiotic microdeletion breakpoints in the BRCA1 gene are signifi cantly associated with symmetric DNA-sequence elements. Am J Hum Genet 61:1454-1456.
290. Schmutte C, Jones PA (1998) Involvement of DNA methylation in human carcinogenesis. Biol Chem 379:377-388.
291. Schollen E, Pardon E, Heykants L, Renard J, Doggett NA, Callen DF, Cassiman JJ, Matthijs G (1998) Comparative analysis of the phosphomannomutase genes PMM1, PMM2 and PMM2psi: The sequence variation in the processed pseudogene is a reflection of the mutations found in the functional gene. Hum Mol Genet 7:157-164.
292. Schroeder SA, Gaughan DM, Swift M (1995) Protection against bronchial asthma by CFTR delta F508 mutation: A heterozygote advantage in cystic fibrosis. Nat Med 1:703-705.
293. Scott HS, Kudoh J, Wattenhofer M, Shibuya K, Berry A, Chrast R, Guipponi M, Wang J, Kawasaki K, Asakawa S, Minoshima S, Younus F, Mehdi SQ, Radhakrishna U, Papasavvas MP, Gehrig C, Rossier C, Korostishevsky M, Gal A, Shimizu N, Bonne-Tamir B, Antonarakis SE (2001) Insertion of beta-satellite repeats identifi es a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness. Nat Genet 27:59-63.
294. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Maner S, Massa H, Walker M, Chi M, Navin N, Lucito R, Healy J, Hicks J, Ye K, Reiner A, Gilliam TC, Trask B, Patterson N, Zetterberg A, Wigler M (2004) Large-scale copy number polymorphism in the human genome. Science 305:525-528.
295. Semenza GL (1994) Transcriptional regulation of gene expression: Mechanisms and pathophysiology. Hum Mutat 3:180-199.
296. Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AG, Antonarakis SE (2007) Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: A mechanism for functional singlenucleotide polymorphisms related to phenotypes. Am J Hum Genet 81(2):405-413.
297. Sgourou A, Routledge S, Antoniou M, Papachatzopoulou A, Psiouri L, Athanassiadou A (2004) Thalassaemia mutations within the 5'UTR of the human beta-globin gene disrupt transcription. Br J Haematol 124:828-835.
298. Shaikh TH, Kurahashi H, Saitta SC, O'Hare AM, Hu P, Roe BA, Driscoll DA, McDonald-McGinn DM, Zackai EH, Budarf ML, Emanuel BS (2000) Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet 9:489-501.
299. Shapiro LJ, Yen P, Pomerantz D, Martin E, Rolewic L, Mohandas T (1989) Molecular studies of deletions at the human steroid sulfatase locus. Proc Natl Acad Sci USA 86:8477-8481.
300. Sharp AJ, Locke DP, McGrath SD, Cheng Z, Bailey JA, Vallente RU, Pertz LM, Clark RA, Schwartz S, Segraves R, Oseroff VV, Albertson DG, Pinkel D, Eichler EE (2005) Segmental duplications and copy-number variation in the human genome. Am J Hum Genet 77:78-88.
301. Sharp AJ, Hansen S, Selzer RR, Cheng Z, Regan R, Hurst JA, Stewart H, Price SM, Blair E, Hennekam RC, Fitzpatrick CA, Segraves R, Richmond TA, Guiver C, Albertson DG, Pinkel D, Eis PS, Schwartz S, Knight SJ, Eichler EE (2006) Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat Genet 38:1038-1042.
302. Sharp PA (1987) Splicing of messenger RNA precursors. Science 235:766-771.
303. Shaw CJ, Lupski JR (2004) Implications of human genome architecture for rearrangement-based disorders: The genomic basis of disease. Hum Mol Genet 13(Spec No 1): 57-64.
304. Shaw MA, Brunetti-Pierri N, Kadasi L, Kovacova V, Van Maldergem L, De Brasi D, Salerno M, Gecz J (2003) Identification of three novel SEDL mutations, including mutation in the rare, non-canonical splice site of exon 4. Clin Genet 64:235-242.
305. Shaw-Smith C, Pittman AM, Willatt L, Martin H, Rickman L, Gribble S, Curley R, Cumming S, Dunn C, Kalaitzopoulos D, Porter K, Prigmore E, Krepischi-Santos AC, Varela MC, Koiffmann CP, Lees AJ, Rosenberg C, Firth HV, de Silva R, Carter NP (2006) Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat Genet 38:1032-1037.
306. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha- Synuclein locus triplication causes Parkinson's disease. Science 302:841.
307. Small K, Iber J, Warren ST (1997) Emerin deletion reveals a common X-chromosome inversion mediated by inverted repeats. Nat Genet 16:96-99.
308. Spitz F, Montavon T, Monso-Hinard C, Morris M, Ventruto ML, Antonarakis S, Ventruto V, Duboule D (2002) A t(2;8) balanced translocation with breakpoints near the human HOXD complex causes mesomelic dysplasia and vertebral defects. Genomics 79:493-498.
309. Spritz RA, Giebel LB, Holmes SA (1992) Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Am J Hum Genet 50:261-269.
310. Stamatoyannopoulos G (1991) Human hemoglobin switching. Science 252:383.
311. Stefansson H, Helgason A, Thorleifsson G, Steinthorsdottir V, Masson G, Barnard J, Baker A et al (2005) A common inversion under selection in Europeans. Nat Genet 37:129-137.
312. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN (2003) Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 21:577-581.
313. Stoppa-Lyonnet D, Duponchel C, Meo T, Laurent J, Carter PE, Arala-Chaves M, Cohen JH, Dewald G, Goetz J, Hauptmann G et al (1991) Recombinational biases in the rearranged C1-inhibitor genes of hereditary angioedema patients. Am J Hum Genet 49:1055-1062.
314. Subramanian S, Kumar S (2006) Evolutionary anatomies of positions and types of disease-associated and neutral amino acid mutations in the human genome. BMC Genomics 7:306.
315. Sunyaev S, Ramensky V, Koch I, Lathe W 3rd, Kondrashov AS, Bork P (2001) Prediction of deleterious human alleles. Hum Mol Genet 10:591-597.
316. Suter CM, Martin DI, Ward RL (2004) Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 36:497-501.
317. Terp BN, Cooper DN, Christensen IT, Jorgensen FS, Bross P, Gregersen N, Krawczak M (2002) Assessing the relative importance of the biophysical properties of amino acid substitutions associated with human genetic disease. Hum Mutat 20:98-109.
318. Thein SL (2004) Genetic insights into the clinical diversity of beta thalassaemia. Br J Haematol 124:264-274.
319. Thomas JW, Touchman JW, Blakesley RW, Bouffard GG, Beckstrom-Sternberg SM, Margulies EH, Blanchette M et al (2003) Comparative analyses of multi-species sequences from targeted genomic regions. Nature 424:788-793.
320. Tishkoff SA, Verrelli BC (2003) Patterns of human genetic diversity: Implications for human evolutionary history and disease. Annu Rev Genomics Hum Genet 4:293-340.
321. Touchon M, Nicolay S, Audit B, BrodieofBrodie EB, d'Aubenton-Carafa Y, Arneodo A, Thermes C (2005) Replication-associated strand asymmetries in mammalian genomes: Toward detection of replication origins. Proc Natl Acad Sci USA 102:9836-9841.
322. Treisman R, Orkin SH, Maniatis T (1983) Specific transcription and RNA splicing defects in five cloned beta-thalassaemia genes. Nature 302:591-596.
323. Tufarelli C, Stanley JA, Garrick D, Sharpe JA, Ayyub H, Wood WG, Higgs DR (2003) Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet 34:157-165.
324. Tuffery-Giraud S, Saquet C, Chambert S, Claustres M (2003) Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy. Hum Mutat 21:608-614.
325. Turner C, Killoran C, Thomas NS, Rosenberg M, Chuzhanova NA, Johnston J, Kemel Y, Cooper DN, Biesecker LG (2003) Human genetic disease caused by de novo mitochondrial-nuclear DNA transfer. Hum Genet 112:303-309.
326. Tusie-Luna MT, White PC (1995) Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sci USA 92:10796-10800.
327. Upadhyaya M, Han S, Consoli C, Majounie E, Horan M, Thomas NS, Potts C, Griffi ths S, Ruggieri M, von Deimling A, Cooper DN (2004) Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofi bromatosis patients with benign and malignant tumors. Hum Mutat 23:134-146.
328. Van Esch H (2006) The Fragile X premutation: New insights and clinical consequences. Eur J Med Genet 49:1-8.
329. van Leeuwen FW, de Kleijn DP, van den Hurk HH, Neubauer A, Sonnemans MA, Sluijs JA, Koycu S, Ramdjielal RD, Salehi A, Martens GJ, Grosveld FG, Peter J, Burbach H, Hol EM (1998) Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279:242-247.
330. Velagaleti GV, Bien-Willner GA, Northup JK, Lockhart LH, Hawkins JC, Jalal SM, Withers M, Lupski JR, Stankiewicz P (2005) Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia. Am J Hum Genet 76:652-662.
331. Verpy E, Leibovici M, Zwaenepoel I, Liu XZ, Gal A, Salem N, Mansour A, Blanchard S, Kobayashi I, Keats BJ, Slim R, Petit C (2000) A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C. Nat Genet 26:51-55.
332. Vidaud D, Vidaud M, Bahnak BR, Siguret V, Gispert Sanchez S, Laurian Y, Meyer D, Goossens M, Lavergne JM (1993) Haemophilia B due to a de novo insertion of a human-specific Alu subfamily member within the coding region of the factor IX gene. Eur J Hum Genet 1:30-36.
333. Vitkup D, Sander C, Church GM (2003) The amino-acid mutational spectrum of human genetic disease. Genome Biol 4:R72.
334. Vnencak-Jones CL, Phillips JA 3rd (1990) Hot spots for growth hormone gene deletions in homologous regions outside of Alu repeats. Science 250:1745-1748.
335. Vogel F, Motulsky A (1986) Human genetics. Springer, Berlin.
336. Vogt G, Chapgier A, Yang K, Chuzhanova N, Feinberg J, Fieschi C, Boisson-Dupuis S et al (2005) Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet 37:692-700.
337. von Ahsen N, Oellerich M (2004) The intronic prothrombin 19911A>G polymorphism influences splicing efficiency and modulates effects of the 20210G>A polymorphism on mRNA amount and expression in a stable reporter gene assay system. Blood 103:586-593.
338. Vyas P, Vickers MA, Simmons DL, Ayyub H, Craddock CF, Higgs DR (1992) Cis-acting sequences regulating expression of the human alpha-globin cluster lie within constitutively open chromatin. Cell 69:781-793.
339. Wacey AI, Cooper DN, Liney D, Hovig E, Krawczak M (1999) Disentangling the perturbational effects of amino acid substitutions in the DNA-binding domain of p53. Hum Genet 104:15-22.
340. Wallace MR, Andersen LB, Saulino AM, Gregory PE, Glover TW, Collins FS (1991) A de novo Alu insertion results in neurofibromatosis type 1. Nature 353:864-866.
341. Wang DG, Fan JB, Siao CJ, Berno A, Young P, Sapolsky R, Ghandour G et al (1998) Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280:1077-1082.
342. Wang Z, Moult J (2001) SNPs, protein structure, and disease. Hum Mutat 17:263-270.
343. Warren ST, Nelson DL (1994) Advances in molecular analysis of fragile X syndrome. JAMA 271:536-542.
344. Watnick TJ, Gandolph MA, Weber H, Neumann HP, Germino GG (1998) Gene conversion is a likely cause of mutation in PKD1. Hum Mol Genet 7:1239-1243.
345. Weatherall DJ, Clegg JB, Higgs DR, Wood WG (2001) The hemoglobinopathies. In: Scriver CR, Beaudet AL, Valle D et al (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 4571-4636.
346. Weber JL, May PE (1989) Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44:388-396.
347. Wells RD, Warren AC (1998) Genetic instabilities and hereditary neurological disorders. Academic, San Diego.
348. Wexler NS, Young AB, Tanzi RE, Travers H, Starosta- Rubinstein S, Penney JB, Snodgrass SR, Shoulson I, Gomez F, Ramos Arroyo MA et al (1987) Homozygotes for Huntington's disease. Nature 326:194-197.
349. Williams TN, Mwangi TW, Wambua S, Peto TE, Weatherall DJ, Gupta S, Recker M, Penman BS, Uyoga S, Macharia A, Mwacharo JK, Snow RW, Marsh K (2005) Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat Genet 37:1253-1257.
350. Williams TN, Wambua S, Uyoga S, Macharia A, Mwacharo JK, Newton CR, Maitland K (2005) Both heterozygous and homozygous alpha+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya. Blood 106:368-371.
351. Witchel SF, Lee PA, Suda-Hartman M, Trucco M, Hoffman EP (1997) Evidence for a heterozygote advantage in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 82:2097-2101.
352. Wolf U (1997) Identical mutations and phenotypic variation. Hum Genet 100:305-321.
353. Wong C, Dowling CE, Saiki RK, Higuchi RG, Erlich HA, Kazazian HH Jr (1987) Characterization of beta-thalassaemia mutations using direct genomic sequencing of amplifi ed single copy DNA. Nature 330:384-386.
354. Woods-Samuels P, Wong C, Mathias SL, Scott AF, Kazazian HH Jr, Antonarakis SE (1989) Characterization of a nondeleterious L1 insertion in an intron of the human factor VIII gene and further evidence of open reading frames in functional L1 elements. Genomics 4:290-296.
355. Woods-Samuels P, Kazazian HH Jr, Antonarakis SE (1991) Nonhomologous recombination in the human genome: deletions in the human factor VIII gene. Genomics 10:94-101.
356. Woodward K, Kendall E, Vetrie D, Malcolm S (1998) Pelizaeus-Merzbacher disease: Identifi cation of Xq22 proteolipid- protein duplications and characterization of breakpoints by interphase FISH. Am J Hum Genet 63:207-217.
357. Wyman AR, White R (1980) A highly polymorphic locus in human DNA. Proc Natl Acad Sci USA 77: 6754-6758.
358. Yang WS, Nevin DN, Peng R, Brunzell JD, Deeb SS (1995) A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc Natl Acad Sci USA 92:4462-4466.
359. Young M, Inaba H, Hoyer LW, Higuchi M, Kazazian HH Jr, Antonarakis SE (1997) Partial correction of a severe molecular defect in hemophilia A, because of errors during expression of the factor VIII gene. Am J Hum Genet 60:565-573.
360. Youssoufian H, Kazazian HH Jr, Phillips DG, Aronis S, Tsiftis G, Brown VA, Antonarakis SE (1986) Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots. Nature 324:380-382.
361. Youssoufian H, Antonarakis SE, Aronis S, Tsiftis G, Phillips DG, Kazazian HH Jr (1987) Characterization of five partial deletions of the factor VIII gene. Proc Natl Acad Sci USA 84:3772-3776.
362. Youssoufian H, Antonarakis SE, Bell W, Griffin AM, Kazazian HH Jr (1988) Nonsense and missense mutations in hemophilia A: estimate of the relative mutation rate at CG dinucleotides. Am J Hum Genet 42:718-725.
363. Yu S, Mangelsdorf M, Hewett D, Hobson L, Baker E, Eyre HJ, Lapsys N, Le Paslier D, Doggett NA, Sutherland GR, Richards RI (1997) Human chromosomal fragile site FRA16B is an amplifi ed AT-rich minisatellite repeat. Cell 88:367-374.
364. Zlotogora J (1994) High frequencies of human genetic diseases: founder effect with genetic drift or selection? Am J Med Genet 49:10-13.
365. Zlotogora J (1997) Dominance and homozygosity. Am J Med Genet 68:412-416.
366. Zlotogora J (1998) Germ line mosaicism. Hum Genet 102:381-386.
367. Zschocke J (2003) Phenylketonuria mutations in Europe. Hum Mutat 21:345-356.